St.Louis-Cape Girardeau CCOP

圣路易斯-开普吉拉多 CCOP

• 批准号: 6469970
• 负责人: PATRICK H HENRY
• 金额: $ 40.9万
• 依托单位: ST.LOUIS-CAPE GIRARDEAU CCOP
• 依托单位国家: 美国
• 财政年份: 1987
• 资助国家: 美国
• 起止时间: 1987-06-01 至 2007-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6469970
• 关键词: behavioral /social science research tag; bladder neoplasm; blood /lymphatic neoplasm; bone marrow transplantation; brain neoplasms; breast neoplasms; busulfan; cancer prevention; cancer registry /resource; cancer rehabilitation /care; carboplatin; chemoprevention; cisplatin; clinical research; community health services; cooperative study; cyclophosphamide; cytokine; dacarbazine; data management; dexamethasone; doxorubicin; etoposide; female reproductive system neoplasm; fluorouracil; gastrointestinal neoplasms; gemcitabine; head /neck neoplasm; health services research tag; hormone therapy; human subject; human therapy evaluation; hydroxyurea; irinotecan; leucovorin; lung neoplasms; medical outreach /case finding; medical rehabilitation related tag; medroxyprogesterone; melanoma; monoclonal antibody; neoplasm /cancer chemotherapy; neoplasm /cancer education; neoplasm /cancer immunotherapy; neoplasm /cancer radiation therapy; neoplasm /cancer surgery; neoplasm /cancer therapy; nutrition aspect of cancer; paclitaxel; patient oriented research; prostate neoplasms; renal cell carcinoma; retinoate; selenium; tamoxifen; temozolomide; thalidomide; vinblastine

DESCRIPTION (provided by applicant): The St. Louis-Cape Girardeau CCOP is a consortium of four hospitals in two separate bi-state health service areas serving parts of eastern Missouri and western Illinois. The Investigators from the St. Louis Metropolitan area are affiliated with one or both of the two hospitals in the consortium and have worked together for the past eighteen years in cancer treatment research protocols and more recently, in cancer control research studies. The Cape Girardeau Investigators have worked with CCOP for the past nine years and are affiliated with two hospitals in that city. During the next five years we expect to accrue at least sixty credits per year for cancer treatment research protocols of the NSABP and SWOG and at least seventy five credits (new participants and follow-up) per year for cancer control and prevention studies. These cancer control credits will be derived primarily from our participation in the Breast Cancer Prevention Trial-1, Prostate Cancer Prevention Trial-1 and the Breast Cancer Prevention Trial-2. We will continue to provide high quality data to the Southwest Oncology Group and the National Surgical Adjuvant Breast and Bowel Project which are our research bases, utilizing the data management system developed during the past eighteen years. In summary, we will continue our excellent performance of the past eighteen years in cancer treatment research studies and extend our more recent participation in cancer control and prevention trials. The past experience and capabilities of the Investigators and Clinical Research Associates provides a strong base for continuing development of this Community Clinical Oncology Program.

描述（由申请人提供）：圣路易斯 - 赛车girardeau CCOP是一个 在两个单独的双州卫生服务领域的四家医院的财团 为密苏里州东部和伊利诺伊州西部服务。调查人员 来自圣路易斯大都市地区的一个或两个 财团里的两家医院，在过去的十八个医院一起工作 癌症治疗研究方案的几年，最近的癌症 控制研究。吉拉多角（Cape Girardeau）调查员与 CCOP在过去九年中，并与两家医院有联系 城市。在接下来的五年中，我们预计至少会产生六十个学分 NSABP和SWOG的癌症治疗研究方案每年 每年至少七十五个学分（新参与者和随访） 癌症控制与预防研究。这些癌症控制学分将是 主要来自我们预防乳腺癌的 试验1，前列腺癌预防试验1和预防乳腺癌 试验2。我们将继续向西南提供高质量的数据 肿瘤学组和国家手术辅助乳房和肠项目 利用了开发的数据管理系统，这是我们的研究基础 在过去的18年中。总而言之，我们将继续我们的优秀 过去18年的癌症治疗研究的表现 并扩展我们最近参与癌症控制和预防 试验。调查人员的过去经验和能力 临床研究协会为继续发展提供了强大的基础 该社区临床肿瘤学计划。